Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0760
Source ID: NCT00184652
Associated Drug: Somatropin
Title: Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Chronic Kidney Disease|End-Stage Renal Disease
Interventions: DRUG: somatropin
Outcome Measures: Primary: Change in surrogate markers of nutrition, After 6 months treatment | Secondary: Quality of Life|Other markers of nutrition
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 140
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2003-04
Completion Date: 2005-09
Results First Posted:
Last Update Posted: 2017-01-24
Locations: Novo Nordisk Investigational Site, København Ø, 2100, Denmark|Novo Nordisk Investigational Site, Odense, 5000, Denmark|Novo Nordisk Investigational Site, Århus N, 8200, Denmark|Novo Nordisk Investigational Site, Berlin, 13353, Germany|Novo Nordisk Investigational Site, Heidelberg, 69115, Germany|Novo Nordisk Investigational Site, Hong Kong, Hong Kong|Novo Nordisk Investigational Site, Holon, 58100, Israel|Novo Nordisk Investigational Site, Kfar Saba, 44281, Israel|Novo Nordisk Investigational Site, Petach Tikva, 49100, Israel|Novo Nordisk Investigational Site, Ramat Gan, 52621, Israel|Novo Nordisk Investigational Site, Tel-Aviv, 64239, Israel|Novo Nordisk Investigational Site, Tzriffin, 70300, Israel|Novo Nordisk Investigational Site, Krakow, 31-501, Poland|Novo Nordisk Investigational Site, Lublin, 20 - 094, Poland|Novo Nordisk Investigational Site, Wolomin, 05-200, Poland|Novo Nordisk Investigational Site, Singapore, 119074, Singapore|Novo Nordisk Investigational Site, Göteborg, 417 17, Sweden|Novo Nordisk Investigational Site, Bern, 3010, Switzerland|Novo Nordisk Investigational Site, Birmingham, B9 5SS, United Kingdom|Novo Nordisk Investigational Site, Coventry, CV2 2DX, United Kingdom|Novo Nordisk Investigational Site, Glasgow, G11 6NT, United Kingdom|Novo Nordisk Investigational Site, Liverpool, L69 3GA, United Kingdom|Novo Nordisk Investigational Site, Manchester, M13 0HZ, United Kingdom|Novo Nordisk Investigational Site, Newcastle, NE7 7DN, United Kingdom|Novo Nordisk Investigational Site, Sheffield, S5 7AU, United Kingdom|Novo Nordisk Investigational Site, Swansea, SA6 6NL, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00184652

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress